Cargando…
Transgenesis and the Management of Vector-Borne Disease
Parasitic, bacterial and viral agents continue to challenge the welfare of humans, livestock, wild life and plants worldwide. The public health impact and financial consequences of these diseases are particularly hard on the already overburdened economies of developing countries especially in the tr...
| Clasificación: | Libro Electrónico |
|---|---|
| Autor Corporativo: | |
| Otros Autores: | |
| Formato: | Electrónico eBook |
| Idioma: | Inglés |
| Publicado: |
New York, NY :
Springer New York : Imprint: Springer,
2008.
|
| Edición: | 1st ed. 2008. |
| Colección: | Advances in Experimental Medicine and Biology,
627 |
| Temas: | |
| Acceso en línea: | Texto Completo |
MARC
| LEADER | 00000nam a22000005i 4500 | ||
|---|---|---|---|
| 001 | 978-0-387-78225-6 | ||
| 003 | DE-He213 | ||
| 005 | 20220116132447.0 | ||
| 007 | cr nn 008mamaa | ||
| 008 | 100301s2008 xxu| s |||| 0|eng d | ||
| 020 | |a 9780387782256 |9 978-0-387-78225-6 | ||
| 024 | 7 | |a 10.1007/978-0-387-78225-6 |2 doi | |
| 050 | 4 | |a TP248.13-.65 | |
| 072 | 7 | |a TCB |2 bicssc | |
| 072 | 7 | |a SCI029000 |2 bisacsh | |
| 072 | 7 | |a TCB |2 thema | |
| 082 | 0 | 4 | |a 660.63 |2 23 |
| 245 | 1 | 0 | |a Transgenesis and the Management of Vector-Borne Disease |h [electronic resource] / |c edited by Serap Aksoy. |
| 250 | |a 1st ed. 2008. | ||
| 264 | 1 | |a New York, NY : |b Springer New York : |b Imprint: Springer, |c 2008. | |
| 300 | |a XVIII, 171 p. |b online resource. | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 347 | |a text file |b PDF |2 rda | ||
| 490 | 1 | |a Advances in Experimental Medicine and Biology, |x 2214-8019 ; |v 627 | |
| 505 | 0 | |a Perspectives on the State of Insect Transgenics -- Alphavirus Transducing Systems -- Paratransgenesis Applied for Control of Tsetse Transmitted Sleeping Sickness -- Bacteria of the Genus Asaia: A Potential Paratransgenic Weapon Against Malaria -- Proposed Uses of Transposons in Insect and Medical Biotechnology -- The Yin and Yang of Linkage Disequilibrium: Mapping of Genes and Nucleotides Conferring Insecticide Resistance in Insect Disease Vectors -- Impact of Technological Improvements on Traditional Control Strategies -- Insect Population Suppression Using Engineered Insects -- Wolbachia- Based Technologies for Insect Pest Population Control -- Using Predictive Models to Optimize Wolbachia-Based Strategies for Vector-Borne Disease Control -- Modifying Insect Population Age Structure to Control Vector-Borne Disease -- Technological Advances to Enhance Agricultural Pest Management -- Applications of Mosquito Ecology for Successful Insect Transgenesis-Based Disease Prevention Programs. | |
| 520 | |a Parasitic, bacterial and viral agents continue to challenge the welfare of humans, livestock, wild life and plants worldwide. The public health impact and financial consequences of these diseases are particularly hard on the already overburdened economies of developing countries especially in the tropics. Many of these disease agents utilize insect hosts (vectors) to achieve their transmission to mammals. In the past, these diseases were largely controlled by insecticide-based vector reduction strategies. Now, many of these diseases have reemerged in the tropics, recolonizing their previous range, and expanding into new territories previously not considered to be endemic. Habitat change, irrigation practices, atmospheric and climate change, insecticide and drug resistance as well as increases in global tourism, human traffic and commercial activities, have driven the reemergence and spread of vector borne diseases. While these diseases can be controlled through interventions aimed at both their vertebrate and invertebrate hosts, no effective vaccines exist, and only limited therapeutic prospects are available for their control in mammalian hosts. Molecular technologies such as transgenesis, which is the subject of this book, stand to increase the toolbox and benefit disease management strategies. | ||
| 650 | 0 | |a Biotechnology. | |
| 650 | 0 | |a Medicine-Research. | |
| 650 | 0 | |a Biology-Research. | |
| 650 | 1 | 4 | |a Chemical Bioengineering. |
| 650 | 2 | 4 | |a Biomedical Research. |
| 700 | 1 | |a Aksoy, Serap. |e editor. |4 edt |4 http://id.loc.gov/vocabulary/relators/edt | |
| 710 | 2 | |a SpringerLink (Online service) | |
| 773 | 0 | |t Springer Nature eBook | |
| 776 | 0 | 8 | |i Printed edition: |z 9781441926821 |
| 776 | 0 | 8 | |i Printed edition: |z 9780387569895 |
| 776 | 0 | 8 | |i Printed edition: |z 9780387782249 |
| 830 | 0 | |a Advances in Experimental Medicine and Biology, |x 2214-8019 ; |v 627 | |
| 856 | 4 | 0 | |u https://doi.uam.elogim.com/10.1007/978-0-387-78225-6 |z Texto Completo |
| 912 | |a ZDB-2-SBL | ||
| 912 | |a ZDB-2-SXB | ||
| 950 | |a Biomedical and Life Sciences (SpringerNature-11642) | ||
| 950 | |a Biomedical and Life Sciences (R0) (SpringerNature-43708) | ||